Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease … essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making … innovation is fundamentally flawed for two reasons. First, it ignores the competitive market pressures that both shape what is …

and stimulating innovation in the biotechnology sector, some policy levers narrow down the patent potential for …